Aislinn Antrim is an associate editor at Pharmacy Times®. She graduated from the University of North Carolina at Chapel Hill in 2019 and is completing her master’s in communication and media at Rutgers University.
Improved Health Equity, Outcomes Reported With Omidubicel for Patients With Blood Cancers
May 2nd 2022Omidubicel is a first-in-class, advanced nicotinamide-enabled stem cell therapy candidate being evaluated as the first potential allogeneic advanced cell therapy donor source for individuals with blood cancers in need of a transplant.
Read More